Home · Business · Oct 5 archive
What happens when clinicians develop new technologies 2026a10010zp
Confirmed
In Short: They developed six low-cost neonatal simulator designs to validate and calibrate ventilators.
During the COVID pandemic, Brazil’s Ministry of Health identified a gap in the global market for appropriate testing equipment for ventilators intended for hospitals in the Unified Health System (SUS).
To address this gap, biomedical engineer Sara Gomes Mello Santiago and her adviser, Henrique Takachi Moriya, PhD, associate professor in the Department of Telecommunications and Control Engineering at the University of São Paulo (USP), partnered with the Institute for Technological Research.
Speaking with Medscape’s Portuguese edition, Santiago emphasized the importance of translating clinical needs into technological solutions.
The key aspect of Biodesign is language," Santiago said. "Biomedical engineering acts as a transducer: It takes the problem presented by the healthcare team and translates it into technological parameters, while also interpreting regulatory standards and creating a practical, reproducible solution for the day-to-day work of clinical engineering in hospitals.
Robson Capasso, MD, a professor of Otolaryngology - Head & Neck Surgery and Program Development Director at Stanford Mussallem Center for Biodesign, highlighted the shift in training doctors and engineers to focus more on understanding the real problem.
"The big change is training doctors and engineers to spend much more time understanding the real problem than trying to invent a product too early," Capasso said.
Rodrigo Bornhausen Demarch, MD, Chief Innovation Officer at Hospital Israelita Albert Einstein, São Paulo, noted the importance of adopting a learner mindset in innovation.
Doctors are trained to be certain and not to make mistakes," Demarch said. "In innovation, this mindset needs to change. Professionals need to adopt the mindset of a learner, quickly test hypotheses, discard what doesn’t work, and rebuild on the basis of what they’ve learned.
Demarch also emphasized the interdisciplinary nature of the Biodesign approach.
"The doctor specializes in clinical pain, the engineer knows how to build and prototype, the business professional understands the business model and how to bring the technology to market," Demarch said.
Background
To address this gap, biomedical engineer Sara Gomes Mello Santiago and her adviser, Henrique Takachi Moriya, PhD, associate professor at the University of São Paulo, partnered with the Institute for Technological Research to develop six low-cost neonatal simulator designs.
At TechCrunch Disrupt 2026, AI leaders from Anthropic, Gamma, and Clay will discuss the challenges and successes of deploying AI in real-world enterprise settings.
What's confirmed
- During the COVID pandemic, Brazil’s Ministry of Health identified a gap in the global market for appropriate testing equipment for ventilators intended for hospitals in the Unified Health System (SUS).
- To address this gap, biomedical engineer Sara Gomes Mello Santiago and her adviser, Henrique Takachi Moriya, PhD, associate professor in the Department of Telecommunications and Control Engineering at the University of São Paulo (USP), partnered with the Institute for Technological Research.
- Speaking with Medscape’s Portuguese edition, Santiago emphasized the importance of translating clinical needs into technological solutions.
- The key aspect of Biodesign is language," Santiago said. "Biomedical engineering acts as a transducer: It takes the problem presented by the healthcare team and translates it into technological parameters, while also interpreting regulatory standards and creating a practical, reproducible solution for the day-to-day work of clinical engineering in hospitals.
- Robson Capasso, MD, a professor of Otolaryngology - Head & Neck Surgery and Program Development Director at Stanford Mussallem Center for Biodesign, highlighted the shift in training doctors and engineers to focus more on understanding the real problem.
- "The big change is training doctors and engineers to spend much more time understanding the real problem than trying to invent a product too early," Capasso said.
- Rodrigo Bornhausen Demarch, MD, Chief Innovation Officer at Hospital Israelita Albert Einstein, São Paulo, noted the importance of adopting a learner mindset in innovation.
- Doctors are trained to be certain and not to make mistakes," Demarch said. "In innovation, this mindset needs to change. Professionals need to adopt the mindset of a learner, quickly test hypotheses, discard what doesn’t work, and rebuild on the basis of what they’ve learned.
- Demarch also emphasized the interdisciplinary nature of the Biodesign approach.
- "The doctor specializes in clinical pain, the engineer knows how to build and prototype, the business professional understands the business model and how to bring the technology to market," Demarch said.
What's still developing
- “If you haven’t understood the problem in depth, you don’t know whether the solution makes sense for the hospital’s workflow or for the payer’s bottom line,” Demarch said.
- The iconic Britpop band are gearing up to hit the road again next year, just two years after their long-awaited comeback tour To use the search feature, we need your consent to load Google Custom Search, which may use cookies or similar technologies.
- The iconic Britpop band set the internet on fire in 2024 when they announced that they would be going on tour the following year - the first time since the band split in 2009.
- Their “Live 25” tour saw the band embark on a 41-long run of shows around the UK and the world, beginning in Cardiff on July 4, and concluding in Sao Paulo, Brazil on November 23.
- “Oasis’ schedule is booked. It’s 12 nights at the Etihad over six weeks starting in June [next year],” the source said.
- An investigation by the Competition and Markets Authority (CMA) was launched, with it discovering that Ticketmaster “may have misled Oasis fans” with unclear pricing.
- When you purchase through links on our site, we may earn an affiliate commission.
- This content is provided by Exco Player and may use cookies or similar technologies.
- When two classes of treatment fail in succession, it is tempting to conclude that the disease is intractable.
- When that happens, clinicians are left to ask: Has the mechanism of action failed, was the dose insufficient, was access to treatment inconsistent, is the diagnosis wrong, or does the current complaint no longer reflect active inflammation?
- Holanda warned, however, that many “false failures” result from poor adherence, underdosing, incorrect dosing frequency, interruptions in dispensing, or an erroneous differential diagnosis.
- “I see this as a positive signal, showing that despite intense competition, there is still a willingness to cooperate,” Jiang Tianjiao, associate professor at the Fudan Development Institute in Shanghai, China, told Al Jazeera.
Sources
- Standardlink
- Medscapelink
- Al Jazeeralink
- The Indian Expresslink
- The-Racelink
- Oilpricelink
- Englishlink
- STATlink
- ScienceAlertlink
- Healthpolicy-Watchlink
- WIREDlink
- Morgridgelink
- WarpBeat — background on What Happens When Clinicians Develop New Technologies? link
- WarpBeat — background on Anthropic, Gamma, and Clay share what happens when enterprises actually deploy AI at TechCrunch Disrupt 2026 link
